Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →
Complete report · Medicare & Medicaid Sweep

Medicare & Medicaid Sweep, November 15, 2026

Published November 15, 2026Coverage November 8–14, 2026, Pacific

Read this edition’s coverage limitations ↓

Executive triage

This week. Dialysis facilities have a December 31, 2026 deadline: CMS's contractor instructions for the CY 2027 end-stage renal disease (ESRD) payment system extend the low-volume payment adjustment to facilities that furnished fewer than 8,000 treatments in each of the past three cost-reporting years and meet the other eligibility rules, in six tiers set by the median treatment count, and a facility must attest by that date to receive the adjustment for payment year 2027, unless extraordinary circumstances justify an exception. Medi-Cal is preparing to enforce ordering, referring and prescribing enrollment: Medi-Cal Rx says that beginning in 2027 pharmacy claims will be paid only if the prescriber is enrolled with an individual National Provider Identifier (NPI), and the September town hall deck of the Department of Health Care Services (DHCS) plans phased claim denials from February 2027, with community inpatient and outpatient hospitals in the February 2028 ordering and referring phase (the timeline is described as currently planned). Medi-Cal Rx also set billing rules for 340B drugs under the revised Rebate Model Pilot of the Health Resources and Services Administration (HRSA), from January 1, 2027: claims may be billed at the 340B ceiling price in effect on the date of service plus the professional dispensing fee, and must be reversed and resubmitted when the net acquisition cost after the rebate differs (at a $0.01 ingredient cost plus the dispensing fee when that net cost is negative). CMS told providers that a new law limits Medicare eligibility by immigration status, with coverage terminations no earlier than February 1, 2027. CMS offered states an optional hold harmless period through June 30, 2027 for the Medicaid work requirement that starts January 1, 2027; whether California will request it was not established. CMS extended for six months the nationwide moratoria on initial Medicare enrollment of new home health agencies and hospices, while again allowing enrolled agencies to add branches and hospices to add practice locations, and the January 2027 home health grouper is out.

Primary stories

CMS issues contractor instructions for the CY 2027 ESRD PPS: low-volume adjustment tiers and December 31, 2026 attestation deadline

High priorityUpdatedRead article →

What changed

On November 12, 2026 CMS issued Transmittal R14043BP (Change Request 14638), the annual update that implements the calendar year (CY) 2027 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) rate updates and policies for Medicare contractors, effective January 1, 2027 with implementation January 4, 2027. It states the CY 2027 base rate of $297.52, expands the low-volume payment adjustment (LVPA) to facilities furnishing fewer than 8,000 treatments in each of the past three cost-reporting years, in six tiers, and extends the LVPA attestation deadline to December 31, 2026: facilities must attest by that date to receive the adjustment for payment year 2027, unless extraordinary circumstances justify an exception. It directs Medicare contractors to extend the attestation deadline for payment year 2027 to December 31, 2026. A companion systems transmittal, R13909CP (Change Request 14551), dated August 7, 2026, was re-communicated on November 13, 2026, with a note that it may now be posted publicly; the CMS transmittals index lists it with an issue date of November 12, 2026. On November 15, 2026 the Federal Register record for the rule still gave an effective date of January 1, 2027 and listed no corrections.

Background

CMS published the CY 2027 ESRD PPS final rule, Federal Register document 2026-22194, on October 30, 2026, effective January 1, 2027. The rule sets the unadjusted bundled payment base rate at $297.52 per treatment, up from $281.71 in 2026, and an eligible facility seeking the low-volume adjustment for payment year 2027 must provide its attestation by December 31, 2026.

Who this affects

ESRD facilities billing Medicare, including dialysis they furnish to beneficiaries with acute kidney injury (AKI).

Why it matters

The December 31, 2026 attestation date is now also in the Medicare contractor instruction, so an eligible facility that misses it should not expect the payment year 2027 adjustment unless its contractor grants an extraordinary-circumstance exception (inference). Tier assignment depends on the median treatment count over the past three cost-reporting years, which finance teams can now check against the published tiers.

Required actions

  • For payment year 2027, an eligible ESRD facility seeking the low-volume adjustment must attest to its Medicare Administrative Contractor (MAC) by 2026-12-31, unless extraordinary circumstances justify an exception (conditional, not universal).

Recommended action

  • Revenue-cycle and finance: model the rate and geographic adjustment against actual treatment mix; separately assess LVPA eligibility, ownership aggregation, cost-report history and tier; prepare the attestation before the deadline if seeking payment.
  • Pharmacy, clinical and contracting: assess binder procurement, supply and transitions for eligible ESRD and AKI patients.
  • Home-dialysis leaders: review training capacity, billing configuration and backup-support arrangements.
  • Quality and laboratory: map the first pre-dialysis monthly phosphorus value into End-Stage Renal Disease Quality Reporting System (EQRS) workflows, check continuity and exclusions, validate historical data.
  • Track CMS and Medicare Administrative Contractor (MAC) implementation guidance; confirm existing requirements remain before discontinuing a prior ESRD Quality Incentive Program (QIP) reporting process.

Implementation playbook

  1. Confirm whether each dialysis facility falls under the expanded low-volume threshold (fewer than 8,000 treatments in each of the past three cost-reporting years, with the other eligibility criteria unchanged) and which of the six tiers applies, from the median treatment count over the past three cost-reporting years. Owner: Finance. Due: 2026-12-01.
  2. Prepare and send the payment year 2027 low-volume attestation to the MAC for each eligible facility seeking the adjustment. Owner: Revenue Cycle and Finance. Due: 2026-12-15, ahead of the December 31, 2026 deadline.
  3. Load the CY 2027 base rate of $297.52 and confirm billing systems are ready for the January 4, 2027 contractor implementation. Owner: Revenue Cycle. Due: 2026-12-31.
  4. Watch the MAC's site for any notice on the attestation. Owner: Revenue Cycle. Due: 2026-12-01, then weekly through December 31, 2026.

Scope and timing

Authority status
Final
Responsible owner
Revenue Cycle and Finance (primary); affected: Pharmacy, Clinical Operations, Contracting, Home Dialysis, Quality, Laboratory
Publication date
2026-10-30
Effective date
2027-01-01
Compliance date
2026-12-31 (low-volume adjustment attestation, eligible facilities seeking the adjustment)
Implementation date
2027-01-04 (Medicare contractor implementation of Transmittal R14043BP, CR 14638)
Other dates
Temporary pediatric ESRD add-on ends 2026-12-31; QIP changes begin with payment year 2029; Transmittal R14043BP issued 2026-11-12; Transmittal R13909CP dated 2026-08-07, re-communicated 2026-11-13

Not established

Final ESRD Quality Reporting System (EQRS) technical specifications and any Noridian notice on the attestation were not checked.

Earlier article: November 8, 2026 edition →

Sources

Medi-Cal readies enforcement of ordering, referring and prescribing enrollment; Medi-Cal Rx says prescriber enrollment for pharmacy claims starts in 2027

Medium priorityNew in this editionRead article →

What changed

On November 12, 2026, Medi-Cal Dental published a special provider bulletin on ordering, referring and prescribing (ORP) enrollment. It restates that providers who order, refer or prescribe for Medi-Cal members must be enrolled in Medi-Cal with their Type 1 National Provider Identifier (NPI) through the Provider Application and Validation for Enrollment (PAVE) system, and says the Department of Health Care Services (DHCS) has published resources to help providers prepare for upcoming ORP enrollment enforcement, including a September 24, 2026 town hall on the planned timeline for claim edit activation. The Medi-Cal Rx Monthly Bulletin of November 1, 2026 says that beginning in 2027, pharmacy claims will be processed and paid only if the individual prescriber on the claim is enrolled in Medi-Cal with an individual (Type 1) NPI, a requirement that also covers pharmacists prescribing under their own authority. The bulletin says managed care plan affiliation or Medicare enrollment does not satisfy the requirement and tells prescribers not yet enrolled to apply immediately. The September 24, 2026 town hall deck says enforcement will be phased by claim type for medical claims and Medi-Cal Rx pharmacy claims, beginning in February 2027 and currently planned for completion in the second quarter of 2028, and that once enforcement is implemented claims will deny if enrollment requirements are not met. Community inpatient and outpatient hospitals and county hospitals are among the provider types the deck lists for the February 2028 ordering and referring phase, and DHCS plans a go or no-go readiness review before each phase.

Background

An earlier Medi-Cal Rx alert, dated February 23, 2026 and now marked archived, set the prescriber enrollment requirement for pharmacy claims to take effect June 26, 2026, and said prescriptions and prior authorization (PA) requests tied to a prescriber not approved by that date would be denied. A July 24, 2026 alert said the point-of-sale message for non-enrolled prescribers was informational only and that claims would not deny on the prescriber's enrollment status at that time. An alert last updated September 9, 2026 said implementation will begin in 2027, that DHCS would present a phased approach to full enforcement at the September 24 town hall, and that submitting an application alone will not satisfy the requirement.

Who this affects

Physicians, nurse practitioners, physician assistants and pharmacists who order, refer or prescribe for Medi-Cal members, including hospital-employed and affiliated prescribers whose prescriptions are filled through Medi-Cal Rx; hospital outpatient pharmacies that bill Medi-Cal Rx.

Why it matters

Inference: once DHCS turns on the claim edits, a prescription written by a prescriber who is not enrolled in Medi-Cal can be denied at the pharmacy with no override, which falls on patients discharged with prescriptions and on hospital outpatient pharmacies. Applications can take months to process, so prescribers not yet enrolled need to apply well before enforcement. The November 1 bulletin gives no date, and the September 24, 2026 town hall deck describes its phased timeline as currently planned.

Required actions

  • Prescribers who order, refer or prescribe for Medi-Cal members must be enrolled in Medi-Cal with their individual (Type 1) NPI through PAVE (stated in the November 12, 2026 Medi-Cal Dental bulletin as a federal and state requirement). Beginning in 2027, Medi-Cal Rx pharmacy claims are paid only when the prescriber on the claim is enrolled (November 1, 2026 Medi-Cal Rx bulletin; exact date not stated).

Recommended action

  • Match the individual NPIs of employed and affiliated prescribers, including pharmacists who prescribe, against the DHCS Enrolled Providers list and start PAVE applications for any not found.
  • Watch the DHCS ORP page and Medi-Cal Rx alerts for confirmed claim-edit dates; the September 24, 2026 deck gives planned months only, and brief outpatient pharmacy and discharge teams on the point-of-sale message for non-enrolled prescribers.

Implementation playbook

  1. Match the individual (Type 1) NPIs of employed and affiliated prescribers, including pharmacists who prescribe, against the DHCS Enrolled Providers list. Owner: Medical Staff Services with Revenue Cycle provider enrollment. Due: 2026-12-15.
  2. Start PAVE applications for every prescriber not found. Owner: Revenue Cycle provider enrollment. Due: 2026-12-31.
  3. Watch the DHCS ORP page and Medi-Cal Rx alerts for confirmed claim-edit dates; the September 24, 2026 deck gives planned months only, then brief outpatient pharmacy and discharge teams. Owner: Pharmacy. Due: check monthly; brief within 10 business days of a date being posted.

Scope and timing

Authority status
Guidance
Responsible owner
Revenue Cycle (provider enrollment), with Pharmacy and Medical Staff Services
Publication date
2026-11-12 (Medi-Cal Dental Provider Bulletin Volume 42, Number 36)
Other dates
2026-11-01: Medi-Cal Rx Monthly Bulletin says the prescriber enrollment requirement for pharmacy claims is to be implemented beginning in 2027 (no exact date stated). 2026-02-23: earlier Medi-Cal Rx alert, now marked archived, had set June 26, 2026. 2026-07-24: Medi-Cal Rx alert said the requirement was not yet active. 2026-09-09: updated Medi-Cal Rx alert said implementation will begin in 2027 and announced the phased approach for the September 24, 2026 DHCS ORP town hall (the deck says enforcement is to begin in February 2027 and is currently planned for completion in the second quarter of 2028).

Not established

The exact start date of each phase is given in the deck by month only, and the deck says the timeline is currently planned, so it can change. The DHCS ORP FAQ was not read. The DHCS ORP page, read on November 15, 2026, still says DHCS will publish a timeline of the planned phases.

Sources

CMS posts home health grouper Version 08.0.27 for January 2027 claims

Medium priorityUpdatedRead article →

What changed

The November 12, 2026 Medicare Learning Network (MLN) Connects newsletter announced the January 2027 release of the Home Health Prospective Payment System Grouper, Version 08.0.27, and pointed to the grouper software webpage for a summary of changes. On November 15, 2026 the CMS 2026 transmittals index still listed the instruction, R13974CP, Quarterly Update to Home Health (HH) Grouper, with implementation January 4, 2027.

Background

CMS Transmittal R13974CP (Change Request 14631), issued September 30, 2026, instructs the use of home health grouper version 08.0.27 for claims with From dates on or after January 1, 2027, implemented January 4, 2027.

Who this affects

Home health agencies that bill Medicare, and their billing and software vendors.

Why it matters

Home health agencies and their billing vendors can now load the grouper that assigns claims with From dates on or after January 1, 2027 to Home Health Resource Groups; a system not updated by January 4, 2027 risks claims grouped under the wrong version (inference).

Implementation playbook

  1. Confirm with the billing vendor that Home Health Grouper Version 08.0.27 is installed and tested for claims with From dates on or after January 1, 2027. Owner: IT and Revenue Cycle. Due: 2026-12-31.
  2. Read the grouper software summary of changes and brief coding staff. Owner: Coding. Due: 2026-12-15.

Scope and timing

Authority status
Final
Responsible owner
IT (affected: Coding, Revenue Cycle, Clinical Operations)
Publication date
2026-09-30
Effective date
2027-01-01 (claim From dates)
Implementation date
2027-01-04

Not established

The grouper software summary of changes was not read.

Earlier article: home-health-grouper-version-08-0-27-for-claim-from-dates-on-or-after-january-1

Sources

CMS extends nationwide Medicare enrollment moratoria on new home health agencies and hospices but again allows branches and new practice locations

Medium priorityNew in this editionRead article →

What changed

The Centers for Medicare & Medicaid Services (CMS) extended and modified its nationwide temporary moratoria on Medicare enrollment of new home health agencies (HHAs) and new hospices, effective November 12, 2026, in two notices filed for public inspection on November 12 and scheduled for Federal Register publication on November 16, 2026. During the 6-month extension the moratoria apply only to initially enrolling HHAs and hospices, including those that must enroll anew after a change in majority ownership (CIMO). The moratoria on adding HHA branches and new hospice practice locations by currently enrolled agencies end as of November 12, 2026. CMS said it consulted the HHS Office of Inspector General (OIG), which agreed there remains a significant potential for fraud, waste or abuse, and it considered and rejected limiting the HHA extension to southern California.

Background

CMS published 6-month nationwide moratoria on enrollment of new HHAs and HHA branches (91 FR 27954) and of new hospices and hospice practice locations (91 FR 27946) on May 15, 2026; they took effect May 13, 2026. A moratorium lasts 6 months and may be extended in 6-month increments. CMS's May notice cited Los Angeles County, where the number of HHAs rose more than 40 percent between 2019 and 2023.

Who this affects

Health systems that own or plan to start, acquire or expand Medicare home health agencies or hospices, including through a change in majority ownership.

Why it matters

A health system cannot newly enroll an HHA or hospice in Medicare during the extension, and an acquisition structured as a change in majority ownership that requires initial enrollment is blocked as well. Currently enrolled agencies may again add HHA branches and hospice practice locations from November 12, 2026, which reopens expansion through existing enrollments (inference). A moratorium does not apply to an enrollment application the Medicare contractor received before the moratorium was imposed.

Recommended action

  • Strategy and post-acute leaders: review home health and hospice expansion or acquisition plans against the extended moratoria, especially deals that would be a change in majority ownership.
  • Provider enrollment: plan branch or practice-location additions for currently enrolled agencies now that those moratoria have ended.

Implementation playbook

  1. Review home health and hospice expansion and acquisition plans against the extended moratoria, flagging any deal that would be a change in majority ownership needing initial enrollment. Owner: Strategy and Business Development with Legal. Due: 2026-12-15.
  2. For currently enrolled agencies, plan any branch or practice-location additions now that those moratoria ended on November 12, 2026. Owner: Provider Enrollment. Due: 2027-01-31.
  3. Read the two notices as published in the Federal Register and confirm they match the public-inspection copies. Owner: Legal. Due: 2026-11-30.

Scope and timing

Authority status
Effective
Responsible owner
Provider Enrollment; Post-Acute Services; Strategy and Business Development; Legal
Effective date
2026-11-12
Other dates
Filed for public inspection 2026-11-12; scheduled Federal Register publication 2026-11-16 (after this edition's coverage week); original moratoria took effect 2026-05-13; extension is for 6 months

Not established

The Federal Register page citations were not yet assigned when the public-inspection copies were read. The notices do not state a calendar end date for the extension. The notices name the states that imposed Medicaid moratoria in response to the May 2026 notices (home health: Ohio and Rhode Island; hospice: Louisiana, Nevada, Ohio, Pennsylvania and Rhode Island); California is not among them. Whether California has any other Medi-Cal home health or hospice moratorium was not checked.

Sources

CMS: new law limits Medicare eligibility by immigration status; coverage terminations no earlier than February 1, 2027

Medium priorityNew in this editionRead article →

What changed

The Medicare Learning Network (MLN) Connects newsletter of November 12, 2026 says that recent changes to the law under the Working Families Tax Cut legislation limit Medicare eligibility to United States citizens or nationals, lawful permanent residents, Cuban and Haitian entrants and Compact of Free Association migrants, who must also meet the other Medicare eligibility requirements. The Social Security Administration (SSA) will mail notices to affected patients, and CMS says coverage terminations will occur no earlier than February 1, 2027. CMS tells Original Medicare providers to identify eligibility through the Health Insurance Portability and Accountability Act (HIPAA) Eligibility Transaction System (HETS), while Medicare Advantage organizations will inform their providers about enrollee eligibility. CMS adds that patients who lose Medicare under the new rules because of immigration status will not be eligible for assistance to pay for a Marketplace plan.

Background

CMS says some patients may lose Medicare coverage and may need help understanding notices, updating their records and finding other coverage. CMS points Original Medicare providers and suppliers to the HIPAA Eligibility Transaction System (HETS) to identify Medicare eligibility.

Who this affects

Hospitals and other Original Medicare providers and suppliers whose patients include people who are not United States citizens, nationals, lawful permanent residents, Cuban and Haitian entrants or Compact of Free Association migrants; patient financial services and eligibility staff.

Why it matters

Inference: from February 1, 2027 at the earliest, some patients registered as Medicare beneficiaries may no longer have Medicare coverage on the date of service, so claims billed on the basis of an earlier eligibility check could deny. Patients losing coverage may also lack Marketplace premium assistance, which raises self-pay and charity-care exposure for the hospital.

Recommended action

  • Confirm that registration re-verifies Medicare eligibility in HETS at each encounter from January 2027, not only at first registration.
  • Prepare financial counseling scripts for patients who receive a Social Security Administration termination notice, including Medi-Cal and charity-care screening.
  • Ask contracted Medicare Advantage plans how they will notify the hospital of enrollee eligibility changes.

Implementation playbook

  1. Set registration to re-verify Medicare eligibility in HETS at each encounter from January 2027, not only at first registration. Owner: Patient Access. Due: 2026-12-31.
  2. Prepare financial counseling scripts for patients who receive a Social Security Administration termination notice, including Medi-Cal and charity-care screening. Owner: Financial Counseling. Due: 2027-01-15.
  3. Ask contracted Medicare Advantage plans how they will notify the hospital of enrollee eligibility changes. Owner: Managed Care Contracting. Due: 2026-12-31.

Scope and timing

Authority status
Guidance
Responsible owner
Revenue Cycle (affected: Patient Access, Financial Counseling, Compliance)
Publication date
2026-11-12
Other dates
Coverage terminations no earlier than 2027-02-01, as CMS states

Not established

The notice names the legislation only as the Working Families Tax Cut legislation (CMS elsewhere identifies it as Public Law No. 119-21); its enactment date and the exact termination date for each patient are not stated in the notice; patients' notices will give their coverage end date.

Sources

CMS offers states an optional hold harmless period through June 30, 2027 for the Medicaid work requirement that starts January 1, 2027

Medium priorityNew in this editionRead article →

What changed

On November 13, 2026, the Centers for Medicare & Medicaid Services (CMS) announced an optional hold harmless period through and including June 30, 2027 for the Medicaid work requirement. States that use it will still assess whether people meet the requirement or are excluded, but will not deny applications or disenroll otherwise eligible people solely for failing to meet it. CMS also strongly encouraged states to maximize automated verification with data they already hold and to send clear, timely notices. The release links to federal guidance on Medicaid.gov for details of the hold harmless period. The guidance is State Medicaid Director (SMD) letter 26-006, dated November 13, 2026. A state requests the period as an optional strategy in its mitigation plan, CMS approves it as part of that plan, and a state need not use it for the whole period. For applications submitted and renewals initiated after the period ends in the state, the state must deny or terminate eligibility when an applicable individual is found ineligible for not meeting the requirement.

Background

On June 1, 2026, CMS issued an interim final rule with comment period (IFC; CMS-2454-IFC) implementing a statutory requirement that certain adults in Medicaid meet a work requirement of 80 hours per month as a condition of eligibility. An adult can meet it for a month by working, completing community service or taking part in a work program for at least 80 hours, enrolling in an educational program at least half time, combining those activities for at least 80 hours, or having monthly income of at least the federal minimum wage multiplied by 80 hours. Some adults are exempt, and some are considered to meet the requirement, for example because they were previously exempt. Beginning January 1, 2027, certain applicants and beneficiaries ages 19 to 64 must meet it unless excluded; 43 states and the District of Columbia cover the affected populations. If a state cannot verify compliance, it must send a notice and give the person 30 calendar days to respond. SMD 26-006 notes that a court recently vacated a portion of the regulations (Massachusetts v. Oz, D. Mass., October 29, 2026); which portion was not established.

Who this affects

Hospitals and clinics that serve adults ages 19 to 64 in the Medicaid adult group (or certain section 1115 demonstrations) who are not pregnant and not entitled to or enrolled in Medicare, their eligibility and financial counseling staff, and patient financial services.

Why it matters

Inference: in a state that elects the full period through June 30, 2027, coverage losses solely for not meeting the requirement would not begin before July 1, 2027, so the risk of uninsured inpatient and emergency visits from this cause shifts to the second half of 2027. States may also offer short-term hardship exceptions for people receiving inpatient or certain other medical services, which makes hospital documentation of a stay relevant to a patient's eligibility. Whether California elects the period was not established.

Recommended action

  • Ask the Department of Health Care Services whether Medi-Cal will use the hold harmless period, and set eligibility-screening workflows to match.
  • Prepare financial counselors to help patients answer state noncompliance notices within the 30-day window.
  • Track how the state will accept proof of an inpatient stay for any hardship exception it adopts.

Implementation playbook

  1. Ask the Department of Health Care Services whether Medi-Cal will request the hold harmless period. Owner: Patient Financial Services. Due: 2026-12-04, ahead of the December 11, 2026 date by which SMD 26-006 asks states starting on January 1, 2027 to notify CMS.
  2. Set eligibility-screening and financial counseling workflows to the state's answer, including help with state noncompliance notices within the 30-day window. Owner: Patient Financial Services. Due: 2026-12-31.
  3. Read SMD 26-006 for the conditions of the period, including its request that states intending to start the period on January 1, 2027 notify CMS by December 11, 2026. Owner: Compliance. Due: 2026-11-30.

Scope and timing

Authority status
Guidance
Responsible owner
Patient Financial Services
Publication date
2026-11-13
Operative date
2027-01-01 (statutory work requirement begins for certain applicants and beneficiaries)
Other dates
Optional hold harmless period through and including 2027-06-30; interim final rule CMS-2454-IFC issued 2026-06-01

Not established

Whether California will request the period was not established.

Sources

Continuing obligations

CMS issues CY 2027 Physician Fee Schedule final rule (CMS-1848-F): conversion factors fall, same-day E/M and 0-day global payment cut, new 340B Part D claims repository duty

High priorityConditional reminderRead article →

What this is

CMS finalized the calendar year (CY) 2027 Physician Fee Schedule (PFS) rule, CMS-1848-F, published November 9, 2026 and effective January 1, 2027. It lowers both conversion factors, cuts payment when an office or outpatient evaluation and management (E/M) visit is furnished on the same day as a 0-day global procedure by the same physician or a physician in the same practice (the condition as CMS proposed it), and requires 340B covered entities to submit claim data to a CMS repository for units of covered Part D drugs dispensed by the entity or its contractors for which a manufacturer provides a 340B discount, for dates of service from January 1, 2027, with the first quarterly submission due September 30, 2027.

Current status

On November 15, 2026, the Federal Register record for document 2026-22743 still gave an effective date of January 1, 2027 and listed no corrections, and the CMS fact sheet was still posted. No correction to the rule appeared among CMS documents published November 8 to 14, 2026.

Who this affects

Physicians and practitioners billed under the PFS, Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs), independent labs paid under the Clinical Laboratory Fee Schedule (CLFS), 340B covered entities that dispense Part D drugs (including through contract pharmacies), Shared Savings Program accountable care organizations (ACOs).

Why it matters

Inference: professional-fee revenue projections for 2027 need the lower conversion factors; charge masters and coding edits need the B1/B2 modifiers in place of G2211; same-day E/M plus 0-day global billing by the same physician or a physician in the same practice (the condition in the proposal) will pay at 80% for the lesser service; 340B programs need a process and data feed for Part D claims for drugs dispensed by the entity or its contract pharmacies for which a manufacturer provides a 340B discount, starting with January 1, 2027 dates of service; remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) programs that use contracted staff have until January 1, 2029 before the employed-clinical-staff requirement applies.

Required actions

  • Apply CY 2027 PFS payment and coding policies to services on or after 2027-01-01 (rule effective 2027-01-01), except where the rule sets a later start, such as the employed-clinical-staff requirement for remote monitoring services, delayed to January 1, 2029.
  • Providers and suppliers that are 340B covered entities: submit the required claim data for covered Part D drugs billed to Medicare Part D and dispensed by the entity or its contractors under a 340B discount to the Medicare Part D Claims Data 340B Repository, for claims with dates of service on or after 2027-01-01; first quarterly submission for 2027-01-01 to 2027-03-31 dates of service due 2027-09-30.

Recommended action

  • Model 2027 professional revenue at the final conversion factors.
  • Update E/M modifier logic (B1, B2) and same-day 0-day global edits before January claims.
  • Assign a 340B program owner to scope Part D repository data elements against the full rule text and contract-pharmacy data access.
  • ACOs applying for 2027-01-01: decide any track change before the Phase 2 window closes 2026-11-17 at noon ET.

Implementation playbook

  1. Load the CY 2027 conversion factors ($32.95 for qualifying alternative payment model (APM) participants, $32.63 for others) into the 2027 professional-fee budget and contract models. Owner: Finance and Medical Group Operations. Due: 2026-12-15.
  2. Update charge capture and claim edits for the reduced payment when an office or outpatient E/M visit is furnished on the same day as a 0-day global procedure by the same physician or a physician in the same practice (the condition as CMS proposed it; confirm it in the published rule), and for modifier B1 in place of G2211 (B2 for Shared Savings Program ACOs and Long-term Enhanced ACO Design (LEAD) Model ACOs). Owner: Revenue Cycle and Coding. Due: 2026-12-31, ahead of the January 1, 2027 effective date.
  3. 340B covered entities: name an owner for submitting claim data to the 340B Repository for covered Part D drugs dispensed by the entity or its contractors for which a manufacturer provides a 340B discount, confirm the data feed for dates of service from January 1, 2027, and calendar the first quarterly submission. Owner: Pharmacy 340B program and Compliance. Due: process ready 2027-01-01; first submission 2027-09-30 (the fact sheet's date).
  4. Shared Savings Program applicants for a January 1, 2027 start: decide on any track change. Owner: ACO leadership. Due: 2026-11-17, noon Eastern (the fact sheet's window).
  5. Read the published rule (91 FR 70992) for provisions the fact sheets do not cover, and correct this entry if the rule text differs. Owner: Compliance. Due: 2026-12-01.

Scope and timing

Authority status
Final
Responsible owner
Revenue Cycle (professional billing); Pharmacy/340B program for the repository duty
Publication date
2026-11-09 (Federal Register, 91 FR 70992). CMS fact sheet and press release dated 2026-11-04; placed on public inspection 2026-11-04
Effective date
2027-01-01
Compliance date
2027-09-30: first mandatory quarterly submission to the 340B Repository, covering dates of service in the first quarter of 2027
Implementation date
Requirement for employed clinical staff in remote monitoring services begins with CY 2029
Other dates
Shared Savings Program applicants for a January 1, 2027 start may change track during the Phase 2 window, 2026-11-12 to 2026-11-17 at noon Eastern

Not established

The 340B repository submission specifications were not checked.

Earlier article: November 8, 2026 edition →

Sources

Medi-Cal youth gender-affirming services (APL 26-018): federal reimbursement limit from October 13, 2026 and hormone transition through April 12, 2027

High priorityConditional reminderRead article →

What this is

Department of Health Care Services (DHCS) All Plan Letter (APL) 26-018, Federal Reimbursement Limitation on Gender-Affirming Care Services for Youth, is listed in the DHCS letter index with the date 09/30/2026. As the October 11 article reported it, the letter limits reimbursement from October 13 for specified gender-affirming surgery, puberty blockers and hormone therapy for Medi-Cal members under 18 and Children's Health Insurance Program (CHIP) members under 19 (services for other medical indications and treatment of complications remain covered when medically necessary), keeps a transition through April 12, 2027 for hormones already being taken as of October 13 (for affected plan members, only under the medical benefit), and requires plans to submit policies, an attestation and copies within 90 calendar days of release, which the article gave as December 29.

Current status

On November 15, 2026, the Department of Health Care Access and Information (HCAI) member page still said that on October 13, 2026 the federal government stopped paying for some gender affirming care for youth, and that youth already taking gender affirming hormones as of October 13, 2026 can keep getting them through Medi-Cal until April 12, 2027. A direct request for All Plan Letter (APL) 26-018 and the DHCS letter index returned a bot-protection page, so the letter and its December 29 plan submission date were not re-verified.

Who this affects

Medi-Cal managed care plans and their network hospitals and providers serving Medi-Cal members under 18 and CHIP members under 19.

Why it matters

As the October 11 article reported it: plans owe DHCS a submission and owe members notices, and providers face reimbursement limits for the listed services for the affected age groups. Verify the letter, its errata, any later DHCS guidance and any court action before acting on a date in this entry.

Required actions

  • Medi-Cal managed care plans: submit policies, attestation and copies within 90 calendar days of the September 30 release (2026-12-29).
  • Plans: distribute approved handbook errata and issue individualized adverse-action notices where required, with ten-day advance notice where applicable, appeal rights and continuation information.
  • Plans (medical benefit): continue hormones already being taken as of October 13 through April 12, 2027.

Recommended action

  • Apply service-date controls and exceptions in billing (Revenue Cycle, by 2026-11-20).
  • Do not cancel or redirect care while state-only funding details develop; the October 11 article reported that the APL advises this, and it was not re-verified against the letter.

Scope and timing

Authority status
Guidance, as the earlier article reported it; current status not verified
Responsible owner
Managed Care (affected: Clinical Operations, Case Management, Revenue Cycle, Legal)
Other dates
2026-12-29: plan policies, attestation and copies due, as the October 11 article reported and not re-verified against the letter; 2027-04-12: youth already taking gender affirming hormones as of 2026-10-13 can keep getting them through Medi-Cal until this date, per HCAI's member page of November 5, 2026 (the October 11 article gave the same date); APL 26-018 released 2026-09-30 as the October 11 article reported; federal payment stopped for some gender affirming care for youth 2026-10-13, per HCAI's member page

Not established

APL 26-018 and its plan submission date were not re-verified; the Department of Health Care Services (DHCS) site refused the request.

Earlier article: November 8, 2026 edition →

Sources

DHCS notice (October 9): Medi-Cal clinic institutional claims submitted from October 15 require diagnosis codes

High priorityConditional reminderRead article →

What this is

In a notice published October 9, 2026, the Department of Health Care Services (DHCS) said that for all Medi-Cal claims submitted on or after October 15, 2026, at least one clinically appropriate International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code is required on a UB-04 claim form or the 837I electronic form by Federally Qualified Health Centers (FQHCs), Rural Health Clinics (RHCs), Indian Health Services (IHS) Memorandum of Agreement (MOA) 638 providers and Tribal FQHCs. The trigger is the claim submission date, not a new date-of-service limit, and the notice says updated provider manual sections will be released in a future Medi-Cal Update. First reported in the October 11 edition.

Current status

On November 15, 2026, a direct request for the Department of Health Care Services (DHCS) notice and the Medi-Cal provider news page returned a page shell with no notice text, so whether a later notice or the promised provider manual update has issued was not checked. The status rests on the browser reading of November 10, 2026, which showed the notice published October 9, 2026 with no updated date.

Who this affects

FQHCs, RHCs, IHS-MOA 638 providers and Tribal FQHCs submitting UB-04 or 837I claims to Medi-Cal, including hospital-affiliated clinics of those types (inference).

Why it matters

Per the October 9 notice, the requirement applies by claim submission date, from October 15, 2026. Inference: a claim from a listed provider type submitted without a qualifying diagnosis code risks rejection or denial.

Required actions

  • As the October 9, 2026 DHCS notice states it (later notices and the provider manual update not checked): FQHCs, RHCs, IHS-MOA 638 providers and Tribal FQHCs include at least one clinically appropriate ICD-10-CM code on UB-04 and 837I Medi-Cal claims submitted on or after October 15, 2026. Confirm against any later DHCS notice and the updated provider manual sections.

Recommended action

  • Keep the diagnosis edit in affected institutional claim workflows and monitor remittances from October 15.
  • Check whether the promised provider manual update has been released, and review it if so.

Implementation playbook

  1. Confirm that every affected provider type and its UB-04 and 837I Medi-Cal claim queues have been identified. The October 11 edition gave October 12, 2026 as a recommended internal target, not an agency date. Owner: Revenue Cycle. Due: 2026-11-25 for any queue not yet confirmed.
  2. Confirm that each affected queue populates a clinically appropriate ICD-10-CM code and rejects internally any claim without one. The October 11 edition gave October 14, 2026 as a recommended internal target, not an agency date. Owner: IT. Due: 2026-11-25.
  3. Monitor submissions and remittances for claims submitted on or after October 15, 2026, the date from which the notice applies the requirement, and resolve coding exceptions. Owner: Coding. Due: weekly, until the updated provider manual sections are released and reviewed.

Scope and timing

Authority status
Requirement as stated in the October 9, 2026 DHCS notice; later notices and the provider manual update not checked
Responsible owner
Revenue Cycle (affected: Coding, IT, Clinical Operations)
Publication date
2026-10-09
Effective date
2026-10-15 (the notice applies the requirement to claims submitted on or after this date)
Other dates
The notice says updated provider manual sections will be released in a future Medi-Cal Update (no date)

Not established

Current status was not checked; the Medi-Cal provider site needs a browser.

Earlier article: November 8, 2026 edition →

Sources

Medicare to pay ASP minus 28 percent, or another set basis where ASP is unavailable, for separately payable 340B-acquired drugs at non-exempt hospitals from January 1, 2027 (pass-through drugs, vaccines and non-opioid pain relief drugs excluded); every separately paid OPPS drug line must carry modifier JG, TB or ND

High priorityConditional reminderRead article →

What this is

In the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) final rule, published November 6, 2026, CMS will pay average sales price (ASP) minus 28 percent for separately payable drugs acquired under the 340B Program at non-exempt hospitals from January 1, 2027 when ASP is available; where ASP is not available, payment is based on wholesale acquisition cost (WAC) minus 28 percent, then 64.53 percent of average wholesale price (AWP), then 100 percent of mean unit cost (MUC), then the invoice price, and certain products such as nonpass-through diagnostic radiopharmaceuticals with claims data continue to be paid on arithmetic MUC; pass-through drugs, vaccines and non-opioid pain relief drugs are excluded, and rural sole community hospitals (SCHs), children's hospitals and cancer hospitals exempt from the prospective payment system (PPS) are exempt. From the same date every separately paid OPPS drug claim line, billed under its Healthcare Common Procedure Coding System (HCPCS) code, must carry modifier JG, TB or ND.

Current status

The Federal Register record for the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) final rule (document 2026-22739) was read on November 15, 2026: it lists no corrections and gives an effective date of January 1, 2027. No correction document for the rule appears among the CMS documents published November 8 through 15, 2026. The rule text was not re-read. The comment close date of January 4, 2027 shown in the record was not reconciled with the rule text. Court dockets were not checked for a challenge to the payment cut.

Who this affects

All hospitals paid under the OPPS, including excepted and non-excepted off-campus provider-based departments, for separately payable drugs. Payment cut applies to 340B covered entity hospitals; rural SCHs, children's hospitals and PPS-exempt cancer hospitals are exempt from the cut and report the informational modifier TB on separately payable drugs bought with a 340B discount (ND on drugs not acquired under 340B). Critical Access Hospitals (CAHs) and Rural Emergency Hospitals (REHs) are outside the OPPS.

Why it matters

This is a claim-level compliance duty for every OPPS hospital, not only 340B participants: non-340B hospitals must append ND to separately paid drug lines from January 1, 2027. Inference: 340B hospitals need line-level split-billing data (340B versus non-340B purchase) in the pharmacy and billing systems by January 1, 2027. Inference: modifier errors could produce overpayments (missing JG) or claim edits; inference: 340B hospitals face a large drug revenue cut partly offset by the 7.50 percent non-drug increase, while non-340B hospitals gain. The rule also amends 42 CFR 427.303(b)(1)(iv) so successor 340B modifiers are used to exclude 340B units from Part B inflation rebates.

Required actions

  • From January 1, 2027, report modifier JG on the same claim line as the drug HCPCS code for 340B-acquired separately payable drugs to which the payment reduction applies (non-exempt OPPS hospitals; the reduction does not reach pass-through drugs, vaccines or non-opioid pain relief drugs with status indicator K1)
  • From January 1, 2027, report modifier TB as the rule's final modifier table directs: the summary lists it for 340B-acquired drugs at rural SCHs, children's hospitals and PPS-exempt cancer hospitals and for pass-through and non-opioid pain relief drugs, and the detailed discussion ties TB to drugs bought with a 340B discount
  • From January 1, 2027, report modifier ND for all separately paid drugs not acquired through the 340B Program (all OPPS hospitals, including excepted and non-excepted off-campus provider-based departments (PBDs))

Recommended action

  • Map 340B accumulator or split-billing data to claim lines and test JG/TB/ND logic before January 1, 2027
  • Audit the first months of 2027 drug claims for modifier completeness
  • Model the net effect of the drug cut and the non-drug budget neutrality increase on CY 2027 revenue

Implementation playbook

  1. Confirm the hospital's status under the 340B payment policy (subject to the reduction, or an exempt rural sole community hospital, children's hospital or PPS-exempt cancer hospital), which decides between modifiers JG and TB. Owner: Reimbursement. Due: 2026-11-30.
  2. Build and test the claim-line modifier logic so that every separately paid drug line carries JG, TB or ND, using the rule's final modifier table. Owner: Revenue Cycle, Pharmacy and IT. Due: testing complete 2026-12-15; live for dates of service from 2027-01-01 (the rule's date).
  3. Reconcile 340B accumulator and split-billing data so that 340B-acquired drugs are identified correctly at the claim line. Owner: Pharmacy 340B program. Due: 2026-12-15.
  4. Model the effect of ASP minus 28 percent, and of the alternative bases where ASP is unavailable, on 340B drug revenue against the estimated 7.50 percent increase to non-drug payments, and update the 2027 budget. Owner: Finance. Due: 2026-12-15.
  5. Check for CMS claims instructions implementing the modifiers. Owner: Compliance. Due: 2026-12-01, then weekly through January 2027.

Scope and timing

Authority status
Final
Responsible owner
Pharmacy / 340B Program (primary); Revenue Cycle; Compliance; Finance
Publication date
2026-11-06
Effective date
2027-01-01
Compliance date
2027-01-01 (modifier reporting on separately paid drug claims)
Other dates
Hospital acquisition cost survey conducted 2026-01-01 through 2026-04-07; Federal Register record lists comments_close_on 2027-01-04 (what the comment period covers not reconciled with the rule text)

Not established

Court dockets were not checked. The final modifier table and CMS claims instructions for the modifiers were not retrieved.

Earlier article: November 8, 2026 edition →

Sources

Hospice election addendum: mandatory since October 1; CMS enforcement discretion on missing or incomplete addenda ends December 31

High priorityConditional reminderRead article →

What this is

CMS made the hospice election statement addendum mandatory for every hospice election on or after October 1, 2026, in the FY 2027 Hospice Prospective Payment System final rule: it must be furnished in writing within 5 calendar days of the election effective date, updates within 3 calendar days of a plan-of-care change, and a valid signed addendum in the record is a condition for payment. From October 1 to December 31, 2026, CMS is exercising enforcement discretion, under which Medicare Administrative Contractors (MACs) will not deny claims solely because the addendum is missing or incomplete; furnishing it remains required.

Current status

The November 12, 2026 Medicare Learning Network (MLN) Connects newsletter, read on November 15, 2026, carries no item on the hospice election addendum or on the enforcement-discretion period, which still ends December 31, 2026 as CMS stated on October 1. The FY 2027 hospice final rule text and 42 CFR 418.24(c) were not re-read.

Who this affects

Medicare-certified hospices, including hospice programs operated by hospitals and health systems.

Why it matters

A hospice election without a valid signed addendum in the hospice medical record does not meet the condition for payment. Inference: after December 31 the newsletter's statement that MACs will not deny claims solely for a missing or incomplete addendum no longer applies; the newsletter does not describe post-December claim handling.

Required actions

  • Furnish the addendum in writing (paper or electronic) to every electing beneficiary or representative, with the content required by 42 CFR 418.24(c), within 5 calendar days of the election effective date (elections on and after 2026-10-01).
  • Furnish any addendum update within 3 calendar days of the plan-of-care change.
  • Keep a valid signed addendum in the beneficiary's hospice medical record (condition for payment).

Recommended action

  • Audit October and November elections and correct omissions (Clinical Operations, by 2026-11-20).
  • Add a pre-billing addendum check before the enforcement-discretion window ends (Revenue Cycle, by 2026-12-15).

Scope and timing

Authority status
Effective
Responsible owner
Clinical Operations (affected: Compliance, Revenue Cycle, IT)
Publication date
2026-10-01 (MLN Connects)
Effective date
2026-10-01 (elections on and after)
Compliance date
Addendum within 5 calendar days of the election effective date; updates within 3 calendar days of a plan-of-care change (rolling)
Other dates
Enforcement-discretion window 2026-10-01 to 2026-12-31

Not established

The final rule text and 42 CFR 418.24(c) were not re-read. The October 1 and November 12, 2026 newsletters do not say how claims will be handled after December 31, 2026; no other CMS source was checked for this.

Earlier article: November 8, 2026 edition →

Sources

DHCS warns assisted living waiver facilities of denials and reprocessing

High priorityConditional reminderRead article →

What this is

In a notice published October 9, 2026, the Department of Health Care Services (DHCS) said claims for Assisted Living Waiver (ALW) services may be non-payable due to non-compliance with program requirements, that it is reviewing previously paid claims, which may result in the reprocessing of claims that were erroneously paid, and that it will follow up with facilities that have non-payable claims. The notice lists what facilities must do to prevent denials, asks that inquiries give the facility name and National Provider Identifier (NPI), and sets no deadline.

Current status

The Medi-Cal provider site could not be read on November 15, 2026: a direct request returned a page with no notice content, so whether the notice was updated or withdrawn since the November 8, 2026 edition was not established. The notice was last seen posted, with no updated date, on November 10, 2026.

Who this affects

Assisted Living Waiver (ALW) facilities and Care Coordination Agencies billing Medi-Cal; health systems that operate or contract with them (inference).

Why it matters

Per the October 9 notice, the exposure is non-payment of Assisted Living Waiver claims that do not meet program requirements, and possible reprocessing of claims DHCS finds were erroneously paid.

Required actions

  • The October 9 notice says that, to prevent claim denials, facilities must ensure they are verifying Assisted Living Waiver eligibility before delivering services and submitting claims, fully complying with program standards, policies and contract requirements, submitting claims with correct procedure codes and modifiers, and reviewing internal processes for accurate claiming and documentation.

Recommended action

  • Validate eligibility and service evidence before billing; reconcile prior payments and preserve facility-specific correspondence.
  • Send questions to the DHCS ALW claims support channel named in the notice, with the facility name and NPI.

Scope and timing

Authority status
Announced
Responsible owner
Revenue Cycle (affected: Case Management, Compliance, Finance)
Publication date
2026-10-09
Other dates
No agency deadline stated; DHCS follow-up is facility-specific

Not established

The Medi-Cal provider site was not read for this edition. Facility-specific DHCS follow-up is not public.

Earlier article: November 8, 2026 edition →

Sources

CDPH AFL 26-34 (dated November 9): CDPH says it will send Medi-Cal revalidation intent letters to facilities beginning November 9; no response within 35 calendar days means termination from Medi-Cal

High priorityConditional reminderRead article →

What this is

The California Department of Public Health (CDPH) All Facilities Letter (AFL) 26-34, dated November 9, 2026, says that beginning that day CDPH will send Medi-Cal revalidation intent letters to each health care facility, asking enrolled providers to revalidate or voluntarily withdraw, and that failure to respond to the intent letter within 35 calendar days will result in termination and deactivation from the Medi-Cal program.

Current status

AFL 26-34 was read again on November 15, 2026 and its text is unchanged: CDPH sends intent letters beginning November 9, 2026, and the 35-calendar-day response rule stands. The CDPH 2026 AFL list read the same day shows AFL 26-34 as the newest letter, with no revision or later letter. Whether the Department of Health Care Services (DHCS) issued a companion notice was not checked.

Who this affects

All CDPH-licensed health facilities enrolled in Medi-Cal

Why it matters

The AFL does not say whether the 35 days count from the intent letter's date or from its receipt. Inference, for planning only: if the 35 days are counted from the date on the intent letter, a letter dated November 9, 2026 would call for a response by December 14, 2026. The AFL does not say when the count starts, and a facility's letter may carry a later date. Inference: an intent letter that is not routed to the person responsible for Medi-Cal enrollment could go unanswered for 35 calendar days, which the AFL says results in termination and deactivation from Medi-Cal. The AFL says instructions are emailed using the licensee's primary contact and facility administrator email addresses reported to CDPH's Centralized Applications Branch.

Required actions

  • A provider that receives a CDPH Medi-Cal revalidation intent letter: respond within 35 calendar days, by confirming intent to revalidate or by withdrawing. The AFL does not say when the count starts; as a planning assumption, count from the date on the intent letter. The letter says no response results in termination and deactivation from Medi-Cal.

Recommended action

  • Tell mailrooms and administrators at every licensed facility address to route any CDPH intent letter to the Medi-Cal enrollment owner the day it arrives.
  • Confirm the licensee primary contact and facility administrator email addresses, and the mailing address, in CDPH's system of record. The AFL says an email address is updated by an email request from the administrator or the licensee's primary contact, and a mailing address by a Change of Mailing Address application packet to the Centralized Applications Branch.
  • Assemble the revalidation application packet in advance, using the CDPH Medi-Cal Revalidation page the letter points to.

Scope and timing

Authority status
Guidance (All Facilities Letter citing 42 CFR 455.414 and Title 22 California Code of Regulations section 51000.55)
Responsible owner
Revenue Cycle (provider enrollment); Compliance; Facility Administration
Compliance date
Response to each facility's intent letter due within 35 calendar days; the letter does not say when the count starts
Implementation date
2026-11-09 (CDPH says intent letters are sent beginning this date)
Other dates
Letter dated 2026-11-09

Not established

Whether DHCS issued a companion notice was not checked. The letter does not say when the 35 days start.

Earlier article: November 8, 2026 edition →

Sources

Continuing items (106)
ItemPriorityDates still aheadWhat stands behind this rowEarlier article
CMS seeks emergency clearance to expand the home health Review Choice Demonstration to CaliforniaMedium priorityNovember 16, 2026 (comment deadline)Partly checked; current status not establishedNovember 8, 2026 edition
CMS issues State Operations Manual Transmittal 251Medium priorityNone recordedAn official source was re-read on November 15, 2026November 8, 2026 edition
CMS finalizes CY 2027 OPPS updateMedium priorityJanuary 1, 2027 (effective)
January 4, 2027: comments received by 2027-01-04 are assured consideration (final rule with comment period)
An official source was re-read on November 15, 2026November 8, 2026 edition
Imaging without contrast at excepted off-campus PBDs moves to the PFS-equivalent rate, except at rural sole community hospitalsMedium priorityJanuary 1, 2027 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
Eight more botulinum toxin injection codes need Medicare OPD prior authorization for dates of service on or after July 1, 2027Medium priorityJanuary 1, 2027 (effective)
July 1, 2027 (operative: dates of service)
An official source was re-read on November 15, 2026November 8, 2026 edition
2027 SNF consolidated-billing update (Transmittal 14003, CR 14658)Medium priorityJanuary 1, 2027 (effective)
January 4, 2027 (implementation)
Partly checked; current status not establishedNovember 4, 2026 edition
DHCS revised notice for proposed ABP SPA 26-0034 (behavioral health treatment)Medium priorityNone recordedPartly checked; current status not establishedNovember 4, 2026 edition
California Rural Health Transformation fundingMedium priorityNone recordedPartly checked; current status not establishedNovember 4, 2026 edition
Reminder: DMEPOS face-to-face/written-order and prior-authorization list updatesMedium priorityJanuary 26, 2027: later phase, as the earlier article reported, with actual implementation and later amendments not verified
April 26, 2027: later phase, as the earlier article reported, with actual implementation and later amendments not verified
Partly checked; current status not establishedNovember 4, 2026 edition
SNF QRP October refresh and January 2027 preview (review date 2026-11-14)Medium priorityNone recordedAn official source was re-read on November 15, 2026November 4, 2026 edition
CMS-4214-P: Part D PBM, MA directory and dual-eligible cost-sharing proposal (comments for assured consideration by 2026-12-15)Medium priorityDecember 15, 2026: To be assured consideration, comments must be received no later than 5 p.m. Eastern Standard Time
October 1, 2027: proposed start of the CY 2028 marketing policies
January 1, 2028: proposed start of the PBM contract and cost-sharing provisions
July 1, 2028: proposed first annual PBM reporting deadline (reports would be due no later than July 1, beginning in 2028)
An official source was re-read on November 15, 2026October 18, 2026 edition
CMS restores SOM Chapter 5 nursing-home complaint investigation and reporting sections (R250SOMA)Medium priorityNone recordedAn official source was re-read on November 15, 2026October 18, 2026 edition
Medi-Cal long-term care claimsMedium priorityFebruary 1, 2027 (effective: service dates on or after, as the earlier article reported; not re-verified)Partly checked; current status not establishedOctober 18, 2026 edition
Medi-Cal DRG Mapper 44.0 denials and payment correctionMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 18, 2026 edition
HHS Hurricane Isaias public health emergencies, Florida and AlabamaMedium priorityNone recordedPartly checked; current status not establishedOctober 18, 2026 edition
October NCD coding update (R13968) has a scheduled implementation date of October 5, 2026Medium priorityApril 5, 2027 (implementation: R14035CP)An official source was re-read on November 15, 2026November 8, 2026 edition
Federal Medicaid and CHIP funding prohibition for specified youth proceduresMedium priorityNone recordedPartly checked; current status not establishedOctober 11, 2026 edition
AB 350 fluoride varnish coverage without cost sharingMedium priorityJanuary 1, 2027: applies to contracts and policies issued, amended or renewed on or after this date, as the earlier article reported, and the statute's own effective date was not separately established
July 1, 2027: DHCS billing guidance due 2027-07-01 (longer-lead) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 1876 plan and insurer nondiscrimination protectionsMedium priorityJanuary 1, 2027 (effective) (as the earlier article reported; not re-verified)
December 15, 2026: Earlier playbook target 2026-12-15 (Compliance testing) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
ACCESS model adds heart failure, COPD, substance use disorder, tobacco cessation and MSK follow-on tracksMedium priorityApril 1, 2027 (implementation: new tracks start)An official source was re-read on November 15, 2026October 11, 2026 edition
Ambulatory Specialty Model 2027 performance yearMedium priorityJanuary 1, 2027 (implementation: performance year 2027 begins)Partly checked; current status not establishedOctober 11, 2026 edition
ACWDL 26-16: asset limits return for Pickle, DAC and DW groupsMedium priorityJanuary 1, 2027 (implementation) (as the earlier article reported; not re-verified)
July 1, 2029: LTC transfer look-back grows to 30 months by 2029-07-01 (longer-lead) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
GLOBE model final ruleMedium priorityNovember 30, 2026 (effective)
January 1, 2027: model start with an initial voluntary manufacturer reporting quarter, as the earlier article reported and not re-verified
April 1, 2027: performance period start, as the earlier article reported and not re-verified
March 31, 2032: performance period end, as the earlier article reported and not re-verified
An official source was re-read on November 15, 2026October 11, 2026 edition
California IRF ownership changes require correct RCD selections and new identifiersMedium priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
RHC and FQHC timeliness waiver for eligible LMFT and psychological associate claimsMedium priorityNovember 29, 2026: waiver submission deadline as the earlier article reported it (an optional waiver, status not verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
SB 1049 gives qualifying claim corrections a minimum filing periodMedium priorityJanuary 1, 2027: the date by which the earlier reminders called for workflows to be ready, and the statute's effective and applicability dates were not verifiedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
SB 950 adds qualifying dementia treatment coverage protectionsMedium priorityJanuary 1, 2027: applies to contracts or policies issued, amended or renewed from this date, as the earlier article reported, and the statute's own effective date was not separately establishedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 1887 sets rare disease drug authorization timingMedium priorityJanuary 1, 2027 (effective: contracts or policies issued, amended or renewed from this date) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
SB 1094 changes biosimilar substitution and formulary requirementsMedium priorityJanuary 1, 2027: applies to qualifying prescription-drug contracts issued, amended or renewed from this date, as the earlier article reported and not re-verified
January 15, 2027: provider-notice deadline as the earlier article reported it
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 2348 revises Medi-Cal enhanced care management implementationMedium priorityJanuary 1, 2027 (effective) (as the earlier article reported; not re-verified)
March 31, 2029: DHCS report to the Legislature by 2029-03-31 (state duty, longer-lead) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
HCBS compensation reporting guidance separates 2027 readiness from 2028 reportsMedium priorityJuly 9, 2027 (compliance: state readiness email to CMS by this date) (as the earlier article reported; not re-verified)
July 9, 2028 (implementation: FFS applicability) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
DMEPOS Round 2028 registrationMedium priorityDecember 1, 2026: bidder registration opens
January 5, 2027: bid window opens
February 1, 2027: bidder registration closes
February 8, 2027: covered document review date
March 10, 2027: bid window closes
January 1, 2028: start of Round 2028, contracts and single payment amounts in effect
An official source was re-read on November 15, 2026October 11, 2026 edition
Every Woman Counts adds retroactive procedure and diagnosis benefitsMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
Hospice claim edits gain transfer and ownership-change bypasses in April 2027Medium priorityApril 1, 2027 (effective)
April 5, 2027 (implementation)
An official source was re-read on November 15, 2026October 11, 2026 edition
Home health consolidated billing removes two supply codes in JanuaryMedium priorityJanuary 1, 2027 (effective)
January 4, 2027 (implementation)
An official source was re-read on November 15, 2026October 11, 2026 edition
Noridian repairs G0260 imaging-code payment edit retroactivelyMedium priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
Temporary network withholds on four county behavioral-health plans (as of the October 5 update)Medium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
Qualified non-citizen notices and county record updatesMedium priorityDecember 1, 2026 (compliance) (as the earlier article reported; not re-verified)
January 1, 2027 (implementation) (as the earlier article reported; not re-verified)
July 1, 2027: State-funded full-scope coverage through 2027-07-01 per the October 5 newsletter (the July MEDIL gives no end date) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
CMS says the home health Review Choice Demonstration expands to California for billing periodsMedium priorityJanuary 18, 2027 (implementation: billing periods beginning on or after, pending approval of revisions to Paperwork Reduction Act package CMS-10599, Office of Management and Budget number 0938-1311)An official source was re-read on November 15, 2026November 8, 2026 edition
CY 2027 Home Health PPS final rule (CMS-1844-F) expands the grounds for retroactive Medicare enrollment revocations, across provider typesMedium priorityJanuary 1, 2027 (effective: Home health payment and quality provisions and the 42 CFR 484.245 changes)
April 1, 2027 (effective: Durable medical equipment (DME) infusion pump benefit expansion)
An official source was re-read on November 15, 2026November 8, 2026 edition
Medi-Cal: members with Unsatisfactory Immigration Status move from managed care to fee-for-serviceMedium priorityJanuary 1, 2027 (effective: as the earlier article reported; not re-verified)Partly checked; current status not establishedNovember 8, 2026 edition
340B remedy offset rises from 0.5 percent to 2 percent of the OPPS conversion factor for CY 2027, running to an estimated CY 2031Medium priorityJanuary 1, 2027 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
CMS removes 637 more services from the inpatient only list and adds at least 619 procedures (618 in the rule summary, plus CPT 64629) to the ASC covered procedures list for CY 2027Medium priorityJanuary 1, 2027 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
2027 physician fee-schedule database instructions (Transmittal 14026, CR 14618)Medium priorityJanuary 1, 2027 (effective)
January 4, 2027 (implementation)
April 5, 2027 (implementation)
July 5, 2027 (implementation)
October 4, 2027 (implementation)
An official source was re-read on November 15, 2026November 4, 2026 edition
Revised NCD criteria for autologous stem cell transplant in multiple myeloma (CAG-00444R2)Medium priorityNone recordedAn official source was re-read on November 15, 2026November 4, 2026 edition
Exchange pre-eligibility verification proposed rule (comments for assured consideration by 2026-11-27)Medium priorityNovember 27, 2026: To be assured consideration, comments must be received by this dateAn official source was re-read on November 15, 2026November 4, 2026 edition
Noridian A60217 R2 (MolDX MASLD/MASH biomarker testing, 0665U)Medium priorityNone recordedAn official source was re-read on November 15, 2026November 4, 2026 edition
Reminder: Home health QRP reconsideration requestsMedium priorityNovember 23, 2026: 11:59 p.m. deadline for agencies that received a noncompliance letter and choose to request reconsiderationAn official source was re-read on November 15, 2026November 4, 2026 edition
DHCS PSC-35 and FAST draft removalMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 18, 2026 edition
Treasury/IRS premium tax credit proposed regulationsMedium priorityNovember 30, 2026 (comment deadline)
December 31, 2026: All proposed: the community-engagement provision would apply to taxable years beginning after 2026-12-31
December 31, 2027: All proposed: the income verification and failure-to-reconcile provisions would apply to taxable years beginning after 2027-12-31
December 8, 2026: All proposed: hearing 2026-12-08 at 10 a.m. Eastern, which may be canceled if no outlines are received
An official source was re-read on November 15, 2026October 18, 2026 edition
DHCS replacement of the English DHCS 7077 LTC eligibility noticeMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 18, 2026 edition
Medi-Cal DME and clinical-laboratory ordering NPI requirementsMedium priorityFebruary 1, 2027 (effective: ordering NPI on claims) (as the earlier article reported; not re-verified)
May 1, 2027 (compliance: ordering NPI actively enrolled as a participating Medi-Cal provider) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 18, 2026 edition
DHCS Phase II IP-CANS alignment (ACL 26-74 / BHIN 26-032)Medium priorityJanuary 1, 2027: provisional implementation date (as the earlier article reported; not re-verified)
March 15, 2027: provisional first annual report date, with further reports 2028-03-15 and 2029-03-15 (as the earlier article reported; not re-verified)
March 15, 2028: 2027-03-15: provisional first annual report date, with further reports 2028-03-15 and 2029-03-15 (as the earlier article reported; not re-verified)
March 15, 2029: 2027-03-15: provisional first annual report date, with further reports 2028-03-15 and 2029-03-15 (as the earlier article reported; not re-verified)
December 31, 2028: provisional training and certification date for existing administrators (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 18, 2026 edition
CMS Marketplace duplicate-coverage and deceased-enrollee subsidy removalsMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 18, 2026 edition
Medi-Cal fee-for-service provider directory completion and update periodsMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 280 provider-directory utility and reliance protectionsMedium priorityJuly 1, 2027 (compliance) (as the earlier article reported; not re-verified)
March 1, 2027: Earlier playbook targets: 2027-03-01 (Patient Access workflow mapping), 2027-07-01 (IT testing) (as the earlier article reported; not re-verified)
July 1, 2027: Earlier playbook targets: 2027-03-01 (Patient Access workflow mapping), 2027-07-01 (IT testing) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 1682 large-group scalp-cooling coverageMedium priorityJanuary 1, 2027: applies to large-group contracts issued, amended or renewed on or after this date, as the earlier article reported, and the statute's own effective date was not separately establishedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 2499 electronic claim-documentation intake standardMedium priorityMay 26, 2028 (compliance) (as the earlier article reported; not re-verified)
November 15, 2026: Earlier playbook targets: 2026-11-15 (Revenue Cycle inventory), 2027-06-01 (IT) (as the earlier article reported; not re-verified)
June 1, 2027: Earlier playbook targets: 2026-11-15 (Revenue Cycle inventory), 2027-06-01 (IT) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 1126 Medi-Cal other-coverage billing protectionsMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
DHCS moves members with unsatisfactory immigration status from managed care to fee-for-serviceMedium priorityDecember 31, 2026 (compliance: managed-care-only providers without FFS enrollment cannot continue caring for affected members after this date) (as the earlier article reported; not re-verified)
January 1, 2027 (implementation) (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
Noridian MolDX billing-article revisions for October 1Medium priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
IRF FY 2027 rulesMedium priorityNovember 17, 2026 (implementation: R14001BP)An official source was re-read on November 15, 2026October 11, 2026 edition
January 2027 ASP and ZIP-code instructionsMedium priorityJanuary 1, 2027 (effective: MPFS, per R14026CP)
January 4, 2027 (implementation: MPFS, per R14026CP)
April 5, 2027 (implementation: MPFS quarterly date, per R14026CP)
An official source was re-read on November 15, 2026October 11, 2026 edition
Medi-Cal updates maintenance dialysis billing for restricted-scope membersMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
DOJ corporate fraud directives name healthcare among program-integrity prioritiesMedium priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
AB 1629 changes noncontracted dental assignment of benefitsMedium priorityJanuary 1, 2027: the date by which the earlier reminders called for workflows to be ready, and the statute's effective and applicability dates were not verifiedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 1843 limits prior authorization for covered hepatitis C antiviralsMedium priorityJanuary 1, 2027 (effective) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
SB 964 creates a qualifying drug dose adjustment request pathwayMedium priorityJanuary 1, 2027 (effective) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
AB 1906 adds qualifying cervical screening home test coverageMedium priorityJanuary 1, 2027 (effective) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
SB 874 requires BHT employee background checksMedium priorityJuly 1, 2027 (implementation) (as the earlier article reported; not re-verified)
January 1, 2029: DHCS utilization data and policy synopsis by 2029-01-01 (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
DHCS specifies BHSA service claiming codes for January 2027Medium priorityJanuary 1, 2027 (implementation: service dates from this date) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
Medicare SNF place of service utility will reprocess overlapping claims in April 2027Medium priorityApril 1, 2027 (effective)
April 5, 2027 (implementation)
An official source was re-read on November 15, 2026October 11, 2026 edition
Medi-Cal RSV vaccine billing expands age eligibility and modifier rulesMedium priorityNone recordedFrom the earlier article; not re-verified for this editionOctober 11, 2026 edition
Medi-Cal obstetric E/M transition retains CPSP and doula exceptionsMedium priorityJanuary 1, 2027: AMA obstetric coding framework begins 2027-01-01 (as described in the notice) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
Home health edit repair addresses purged Notices of Admission in April 2027Medium priorityApril 1, 2027 (effective)
April 5, 2027 (implementation)
An official source was re-read on November 15, 2026October 11, 2026 edition
HETS enrollment email verificationMedium priorityDecember 1, 2026 (compliance: suspension follows failed delivery on all three of 2026-10-01, 2026-11-01 and 2026-12-01, as earlier reporting stated, not re-verified)Partly checked; current status not establishedOctober 11, 2026 edition
Recuperative care changesMedium priorityJanuary 1, 2027 (effective) (as the earlier article reported; not re-verified)
December 1, 2026 (compliance) (as the earlier article reported; not re-verified)
December 31, 2026: UIS-transition STPHH cutoff 2026-12-31 (as the earlier article reported; not re-verified)
January 10, 2027: final monitoring report 2027-01-10 (as the earlier article reported; not re-verified)
From the earlier article; not re-verified for this editionOctober 11, 2026 edition
Behavioral-health data sharing needs separate MCP and county implementation phasesMedium priorityJanuary 1, 2027 (implementation) (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 11, 2026 edition
Noridian peripheral nerve injection LCD L40265 and article A60300Medium priorityNone recordedAn official source was re-read on November 15, 2026November 8, 2026 edition
QPP in the CY 2027 PFS final ruleLower priorityJanuary 1, 2027: CY 2027 performance period begins 2027-01-01An official source was re-read on November 15, 2026November 8, 2026 edition
DHCS issues BHIN 26-034 on CARE Act reimbursement rates and billingLower priorityNone recordedPartly checked; current status not establishedNovember 8, 2026 edition
OIG audit: HRSA made $658 million in potential overpayments to selected Phase 3 Provider Relief Fund recipients and should seek repaymentLower priorityNone recordedPartly checked; current status not establishedNovember 8, 2026 edition
Hospital OQR and ASCQR drop the colonoscopy follow-up measureLower priorityJanuary 1, 2027 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
CMS-1850-FC comment periodLower priorityJanuary 1, 2027 (effective)
January 4, 2027: comments received by 2027-01-04 are assured consideration (as printed: 'by [January 4, 2027.')
An official source was re-read on November 15, 2026November 8, 2026 edition
Software as a Medical Service gets new status indicator O1Lower priorityJanuary 1, 2027 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
CMS Medicaid and CHIP Program Integrity PillarsLower priorityNone recordedAn official source was re-read on November 15, 2026November 4, 2026 edition
DDS denies transportation-rate benchmark petitionLower priorityDecember 31, 2030: rate-reform regulations due by 2030-12-31 (as the earlier article reported; not re-verified)From the earlier article; not re-verified for this editionOctober 18, 2026 edition
MLN Matters MM14653Lower priorityApril 1, 2027 (effective)
April 5, 2027 (implementation)
An official source was re-read on November 15, 2026November 8, 2026 edition
OIG organ-acquisition auditLower priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
CMS corrects the comment docket number for the proposed rule implementing sections 6219, 6220 and 6224 of the Consolidated Appropriations Act, 2026 (CMS-4214-P)Lower priorityDecember 15, 2026: To be assured consideration, comments must be received no later than 5 p.m. Eastern Standard TimeAn official source was re-read on November 15, 2026November 8, 2026 edition
Transmittal R14035CP (CR 14645)Lower priorityApril 5, 2027 (implementation)An official source was re-read on November 15, 2026November 8, 2026 edition
Medi-Cal updates payment rates for selected 2026 procedure codesLower priorityNone recordedPartly checked; current status not establishedNovember 8, 2026 edition
ASC rates rise 2.3 percent for CY 2027 for ASCs that meet quality reporting requirementsLower priorityJanuary 1, 2027 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
Two closed teaching hospitals' resident slots open for application through MEARIS until February 2, 2027Lower priorityFebruary 2, 2027: (application deadline)An official source was re-read on November 15, 2026November 8, 2026 edition
Pass-through and packaging for CY 2027Lower priorityJanuary 1, 2027 (effective)
December 31, 2026: 49 drugs' pass-through status expires by 2026-12-31
An official source was re-read on November 15, 2026November 8, 2026 edition
CMS issues final rule codifying the Medicare Drug Price Negotiation Program for 2029 and later (CMS-4215-F)Lower priorityDecember 5, 2026 (effective)An official source was re-read on November 15, 2026November 8, 2026 edition
Noridian updates its nusinersen (SPINRAZA) billing and coding education articleLower priorityNone recordedAn official source was re-read on November 15, 2026November 8, 2026 edition
Cell and Gene Therapy Access Model expansionLower priorityNone recordedAn official source was re-read on November 15, 2026November 4, 2026 edition
Nursing-home MDS validation technical expert panel nominations (close 2026-11-30)Lower priorityNovember 30, 2026: Nominations close 2026-11-30 (voluntary)An official source was re-read on November 15, 2026November 4, 2026 edition
OIG $587.7 million Part D OTC-labeling auditLower priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
OIG $72 million MA and Part D payments tied to revoked providersLower priorityNone recordedAn official source was re-read on November 15, 2026October 11, 2026 edition
DWC updates workers' compensation inpatient hospital fee schedule for services on or after December 1, 2026Lower priorityDecember 1, 2026: Effective date is for services rendered on or after 2026-12-01, as statedAn official source was re-read on November 15, 2026November 8, 2026 edition
CMS program-integrity contractor process transmittal R14002PI (implementation 2026-11-27)WatchNovember 27, 2026: implementation date on the retained transmittal listAn official source was re-read on November 15, 2026November 4, 2026 edition
CMS announces $10 billion second-year Rural Health Transformation Program awards to all 50 states (November 9)WatchNone recordedPartly checked; current status not establishedNovember 8, 2026 edition
Nov 4 M&M context items (OIG four-state nursing-home spending review, HHVBP appeals guide, Louisiana capitation audit, OIG drug-code mapping, FFE unauthorized enrollment, agent-of-record guidance, subsidy matching notice)WatchNone recordedFrom the earlier article; not re-verified for this editionNovember 4, 2026 edition

No longer carried

Items no longer carried (3)
ItemPriorityDates still aheadWhy it leaves the listEarlier article
Noridian A57079 R7 (tendon, ligament and ganglion cyst injections)Medium priorityNone recordedThe date it carried has passed, or the earlier record marked it completeNovember 8, 2026 edition
Noridian revises MolDX minimal residual disease article A58454 (R20)Lower priorityNone recordedThe date it carried has passed, or the earlier record marked it completeNovember 8, 2026 edition
Noridian portal now accepts up to five files at once for prior authorization requestsLower priorityNone recordedThe date it carried has passed, or the earlier record marked it completeNovember 8, 2026 edition

Found after the window closed

Noridian JE Part B: Ask the Contractor Meeting December 9; pre-submitted questions due November 23

Lower priorityConditional reminder

What changed

The Noridian JE Part B update list read on November 15, 2026 still shows the November 9 notice to submit questions by November 23 and lists the December 9, 2026 webinar.

Who this affects

JE Part B providers and billers.

Why it matters

Voluntary.

Recommended action

  • Professional billing: send any questions by 2026-11-23.

Scope and timing

Authority status
Announced
Responsible owner
Revenue Cycle
Publication date
2026-11-09
Other dates
Pre-submitted questions by 2026-11-23; meeting 2026-12-09

Earlier article: noridian-je-part-b-ask-the-contractor-meeting-december-9-pre-submitted-questions

Sources

Earlier developments first reported here

Medi-Cal Rx sets 340B billing rules for drugs under HRSA's revised Rebate Model Pilot starting January 1, 2027

Medium priorityNew in this editionRead article →

What changed

On November 1, 2026, Medi-Cal Rx issued an alert on the Health Resources and Services Administration (HRSA) 340B Rebate Model Pilot Program. HRSA announced a revised Pilot on July 31, 2026, with approved rebate plans scheduled to take effect January 1, 2027; participating manufacturers may provide the 340B ceiling price through a post-purchase rebate instead of an upfront discount. From January 1, 2027, pharmacy providers may submit Medi-Cal Rx 340B claims for Pilot drugs using the 340B ceiling price in effect on the date of service plus the professional dispensing fee, and must reverse and resubmit claims when the net actual acquisition cost after the rebate differs.

Background

The revised Pilot follows the 2026 Pilot, whose implementation was suspended after federal litigation, according to the alert. California law requires Medi-Cal 340B claims to be billed at no more than the covered entity's actual acquisition cost plus the dispensing fee.

Who this affects

Hospitals and other 340B covered entities whose pharmacies bill Medi-Cal Rx for outpatient drugs, and their pharmacy, 340B program and revenue cycle teams.

Why it matters

Inference: for Pilot drugs, the price paid upfront may be higher than the 340B price until the manufacturer rebate arrives, so a claim billed at the ceiling price may later need correcting. Inference: pharmacies will need to track rebates by claim; the alert says a claim can be rebilled up to 12 months from the date of service with appropriate documentation.

Required actions

  • From January 1, 2027, pharmacy providers in the 340B program that bill Medi-Cal Rx for Pilot drugs at the 340B ceiling price must submit the initial claim at the ceiling price plus the professional dispensing fee in effect on the date of service.
  • After the manufacturer rebate is received, they must reverse and resubmit the claim at the correct net actual acquisition cost, or at the non-340B price if the rebate was denied, when the net cost differs from the ceiling price billed. If the net actual acquisition cost after receipt of the rebate is a negative amount, providers should bill $0.01 as the claim's ingredient cost, plus the applicable professional dispensing fee.

Recommended action

  • Have 340B and pharmacy teams identify which manufacturers have approved Pilot rebate plans and which Medi-Cal Rx claims will involve those drugs.
  • Set up a process to match manufacturer rebates to Medi-Cal Rx claims and rebill within the 12-month window, keeping the documentation the alert says audits may request.

Implementation playbook

  1. Identify which manufacturers have approved Pilot rebate plans and which Medi-Cal Rx claims will involve their drugs. Owner: 340B Program. Due: 2026-12-15.
  2. Configure Medi-Cal Rx claims for Pilot drugs at the 340B ceiling price plus the professional dispensing fee in effect on the date of service, from January 1, 2027. Owner: Pharmacy and Revenue Cycle. Due: 2026-12-31.
  3. Set up rebate-to-claim matching so claims are reversed and resubmitted at the net actual acquisition cost (when that cost is negative, a $0.01 ingredient cost plus the applicable professional dispensing fee), or at the non-340B price if a rebate is denied, within 12 months of the date of service, and keep the documentation audits may request. Owner: 340B Program and Revenue Cycle. Due: 2027-01-31.

Scope and timing

Authority status
Guidance
Responsible owner
Pharmacy; 340B Program; Revenue Cycle
Publication date
2026-11-01
Effective date
2027-01-01 (start of the billing rules for drugs under the revised Rebate Model Pilot)
Other dates
HRSA announced the revised Pilot on July 31, 2026, as the alert reports.

Not established

HRSA's July 31, 2026 announcement and the Pilot page were not read; which manufacturers have approved rebate plans is not established. The litigation status is as the alert reports it.

Sources

CMS asks each hospital on the CJR-X participant list to name two primary contacts ahead of the mandatory joint replacement model starting January 1, 2028

Lower priorityNew in this edition

What changed

The Comprehensive Care for Joint Replacement Expanded (CJR-X) Model page of the Centers for Medicare & Medicaid Services (CMS) Innovation Center asks hospitals to submit an online Primary Point of Contact Identification Form for each hospital on the CJR-X participant list, naming two individuals who will receive CJR-X communications from CMS. The page was last modified November 3, 2026; it gives no date for the request and no deadline.

Who this affects

Acute care hospitals paid under the Inpatient Prospective Payment System (IPPS) that are on the CJR-X participant list. CMS says certain hospitals will be exempt, including those participating in the Transforming Episode Accountability Model (TEAM), those located in Maryland and those not eligible to be paid under both the IPPS and the Outpatient Prospective Payment System (OPPS).

Why it matters

Hospitals that do not name contacts may miss CMS communications about CJR-X data, target prices and onboarding before the January 1, 2028 start (inference).

Recommended action

  • Check whether each hospital on the CJR-X participant list has submitted the contact form and named two contacts.

Scope and timing

Authority status
Announced
Responsible owner
Revenue Cycle (value-based programs), with Orthopedic Service Line
Operative date
2028-01-01 (model start)
Other dates
Date of the request not stated; the CJR-X page was last modified 2026-11-03 at 02:12 PM; no response date is given

Not established

The date CMS posted the request and any response deadline were not established. The contact form itself was not opened.

Sources

CMS approves California SPA 26-0020 updating fiscal year 2026-27 Medi-Cal DRG payment parameters

Lower priorityNew in this edition

What changed

The Department of Health Care Services (DHCS) lists State Plan Amendment (SPA) 26-0020 as approved on November 5, 2026. The SPA updates State Fiscal Year 2026-27 Diagnosis Related Group (DRG) payment parameters for general acute inpatient services provided by private hospitals and non-designated public hospitals in California, out-of-state (border and non-border) hospitals, and hospitals designated by Medicare as critical access hospitals.

Who this affects

Private hospitals and non-designated public hospitals in California, out-of-state border and non-border hospitals, and critical access hospitals paid under Medi-Cal DRG, and their revenue cycle and reimbursement teams.

Why it matters

Approval gives the fiscal year 2026-27 DRG parameters federal sign-off; reimbursement teams can compare them with the parameters DHCS published for the year once the SPA pages are read.

Scope and timing

Authority status
Approved State Plan Amendment
Responsible owner
Revenue Cycle; Reimbursement
Other dates
2026-11-05 (approval date, as the DHCS approved-SPA list prints it); the publication date is not established; the approval letter and the SPA effective date were not read

Not established

The SPA 26-0020 approval letter and pages were not read: effective date, parameter values and budget impact not established.

Sources

PRRB upholds contractor exclusion of Medicare Advantage transplants from the Medicare usable-organ count in organ acquisition cost appeal (2026-D30)

Lower priorityNew in this edition

What changed

The Provider Reimbursement Review Board (PRRB) found in decision 2026-D30 that the Medicare contractor properly calculated a Texas transplant hospital's fiscal year 2014 to 2016 organ acquisition costs, in an appeal over excluding organs transplanted into Medicare Advantage enrollees from the Medicare usable-organ count. In 2026-D33 the Board upheld January 13, 2021 as the effective date of a sole community hospital designation, which the contractor and CMS had determined was the date the complete application was received. 2026-D30 was signed September 24, 2026, and 2026-D34, the latest decision listed, September 30, 2026, before the window.

Who this affects

Transplant hospitals that claim organ acquisition costs on the Medicare cost report.

Why it matters

Inference: transplant hospitals with pending or planned appeals on Medicare Advantage organ counts face an adverse Board reading of the rules for those cost years.

Recommended action

  • Reimbursement staff at transplant hospitals should review 2026-D30 against any open organ acquisition appeals.

Scope and timing

Authority status
Disposition
Responsible owner
Finance (affected: Reimbursement, Transplant services)
Other dates
Decision 2026-D30 signed 9/24/2026; decision 2026-D34 signed 9/30/2026

Not established

Whether the CMS Administrator has taken these decisions up for review is not established; the Administrator's listing is undated.

Sources

CMS sets December 7 deadline for Medicare Advantage regional preferred provider plans to request 2027 essential hospital designations of non-contracted rural hospitals

Lower priorityNew in this edition

What changed

A Health Plan Management System (HPMS) memo dated November 3, 2026 tells Medicare Advantage Regional Preferred Provider Organizations (RPPOs) how to ask CMS to designate non-contracting rural hospitals as essential hospitals for contract year 2027. Plans must submit a hospital designation table, a signed good-faith attestation and written documentation of their contracting attempts by Monday, December 7, 2026. Plans approved for 2026 must re-submit those hospitals for 2027. CMS will review and approve requests before December 31, 2026, and Noridian administers the essential hospital bonus payments.

Who this affects

Rural hospitals that do not contract with a Medicare Advantage Regional Preferred Provider Organization (RPPO) and that such a plan proposes to designate as an essential hospital; the plans themselves.

Why it matters

A rural hospital that declined a regional plan's contract may be listed on that plan's designation table, which rests on the plan's written record of offers to the hospital. A plan approved to designate a non-contracting hospital must establish an electronic claims transmission connection with Noridian that complies with the Health Insurance Portability and Accountability Act (HIPAA); Noridian is the Medicare Administrative Contractor that administers essential hospital bonus payments for CMS. Inference: managed-care contracting staff may receive a plan's offer letters or documentation requests before December 7.

Recommended action

  • Rural hospitals: keep a dated record of any contract offer from a Medicare Advantage regional preferred provider plan and of the hospital's response.
  • Confirm with patient financial services how claims for a designated plan's enrollees would be billed and paid.

Scope and timing

Authority status
Guidance
Responsible owner
Managed Care Contracting
Compliance date
2026-12-07 (plan submission deadline)
Other dates
Memo dated 2026-11-03; CMS review and approval before 2026-12-31; posted in the CMS weekly memo archive for November 2 to 6 (report period date 2026-11-06)

Not established

Whether any Medicare Advantage regional preferred provider plan operates in California or designates a California hospital was not established. The bonus payment amount is not stated in the memo.

Sources

Noridian comment periods on five proposed LCDs, including knee hyaluronic acid injections, closed November 14

WatchNew in this edition

What changed

Noridian's Jurisdiction E Part A proposed local coverage determination (LCD) page lists five proposed LCDs, each with a billing and coding article, released for comment on October 1, 2026 with comment periods ending November 14, 2026: Automated Detection and Quantification of Brain MRIs; Hyaluronic Acid Injections for Knee Osteoarthritis; Near-Infrared Spectroscopy (NIRS) in Wound and Flap Management; Real-Time Fluorescence Wound Imaging for Bacterial Presence; and Surgical Treatment of Nails. The Medicare Coverage Database record for the hyaluronic acid proposed LCD (DL40456) also notes that comments ended November 14, 2026.

Who this affects

California hospitals and clinicians billing Noridian Jurisdiction E for knee hyaluronic acid injections, automated brain MRI quantification, near-infrared spectroscopy in wound and flap care, fluorescence wound imaging and surgical nail treatment.

Why it matters

Inference: final versions could narrow coverage or add documentation conditions for these services after a notice period; the comment window has closed, so the next step to watch is publication of final LCDs.

Recommended action

  • Ask orthopedics, wound care and neuroradiology leads to watch for final LCDs and their notice periods.

Scope and timing

Authority status
Proposed
Responsible owner
Revenue Cycle (affected: Coding, Orthopedics, Wound Care, Radiology)
Publication date
2026-10-01
Comment deadline
2026-11-14
Other dates
Release date 10/01/26 and end of comment period 11/14/26 as Noridian's table prints them

Not established

The proposed LCD texts were not read, so what each would cover or limit is not established.

Sources

Forward horizon

0 to 30 days

31 to 60 days

61 to 90 days

91 to 180 days (payer horizon)

Beyond 180 days (long lead)

Coverage limitations

Triggered sources. Each triggered source has a recorded relevance decision. Reviewed this week include FDA recalls and early alerts (the FDA drug shortage pages and the compounding warning-letter search were not read), the Health Resources and Services Administration (HRSA) and the organ transplant network, CDC health alerts and the Morbidity and Mortality Weekly Report (MMWR), HHS appeals board decisions (the Medicare Appeals Council index returned Page Not Found), the Administration for Strategic Preparedness and Response (ASPR), the Equal Employment Opportunity Commission (EEOC), the National Labor Relations Board (NLRB), USCIS (U.S. Citizenship and Immigration Services), IRS, the federal Occupational Safety and Health Administration (OSHA), the Environmental Protection Agency (EPA), the Nuclear Regulatory Commission (NRC), the USITC (U.S. International Trade Commission) and several California boards and departments. Partly covered: DEA, the Substance Abuse and Mental Health Services Administration (SAMHSA) and 42 CFR Part 2, HHS cybersecurity products, court opinions, accreditors, Agency for Healthcare Research and Quality (AHRQ) patient safety organizations, the Medical Board and the Board of Registered Nursing, the Health Plan Management System (HPMS) and the Office of Refugee Resettlement. Not reached: the Labor Department, the Federal Communications Commission (FCC), the federal emergency medical services (EMS) office, notices of the California Emergency Medical Services Authority (EMSA) and the Department of Toxic Substances Control (DTSC).

Sources that need a person. A few sources stopped at a human-verification check or a security challenge and were not worked around: a state license search, some U.S. Attorney release pages for carried enforcement items, Justice Department speech and news listings, the Joint Commission news pages and the DTSC newsroom. Carried items that depend on those pages say what their statements rest on.

How claims were checked. Every quoted passage behind a statement was checked against a saved copy of the source document it came from. Some sources could be read only in a browser; those statements rest on a text capture of the page rather than the original document.

Closing statement. Finished with coverage gaps. Not complete this week: HHS and Office for Civil Rights (OCR) FAQ entries; Justice Department speeches and Justice Manual revisions; CMS Innovation Center bulletins; State Public Health Officer orders, news from the California Department of Industrial Relations (DIR) and EMSA notices; Medicare Learning Network (MLN) Matters Special Editions not tied to a change request; Medicare coverage records after November 6, Quality Payment Program (QPP) announcements and the Comprehensive Error Rate Testing (CERT), Program for Evaluating Payment Patterns Electronic Report (PEPPER) and Unified Program Integrity Contractor (UPIC) channels; California approval lists on Medicaid.gov and dates of pending state plan amendments; Department of Health Care Services (DHCS) rate, Hospital Quality Assurance Fee (HQAF) and directed-payment notices and enrollment notices; DHCS audit postings; CMS Administrator decisions; and Office of Administrative Law (OAL) recent actions. Each is searched again next week.

Source families

  • Federal Register (Reviewed): Every document published 2026-11-01 to 2026-11-14 (the window and the reopened week) was listed through the Federal Register API and screened, agency by agency (58 ledger rows).
  • HHS and OCR (Partial): Read in the browser: HHS press room and OCR newsroom, OCR guidance pages, HRSA news, 340B program updates and program-integrity pages, and OPTN at its new hrsa.gov address. Not done: individual OCR FAQ entries were not opened, so an FAQ revision dated in the window is not ruled out. hhs.gov refuses direct requests.
  • HHS OIG (Reviewed): What's New, reports and publications by issue date, advisory opinions, compliance guidance, alerts, FAQs, news releases and the work plan checked for the window.
  • Justice Department policy (Partial): Main Justice policy releases screened through the press release API. Not done: the speeches listing (a human-verification check, no API) and a Justice Manual revision list (none exists; seven healthcare-relevant titles read, none revised in November 2026).
  • CMS (Partial): Federal Register and public inspection, CMS rules and guidance, SMD 26-006 (read in the browser) and the Innovation Center models page and dataset were checked. Not done: Innovation Center email bulletins (the GovDelivery archive redirects to a sign-in page) and what changed on model pages that carry no modified date.
  • ASTP/ONC (Reviewed): ONC newsroom, blog, news releases, the healthit.gov content API for items published or modified in the window, and the regulation, information blocking and certification pages.
  • FTC (Reviewed): FTC press releases for the window and cases and proceedings read in the browser; the three FTC Federal Register documents in the window screened.
  • California Legislature (Reviewed): All five checks done in the browser: bill search with a control search for the date filter, Assembly and Senate floor actions from that result set, the official history of each measure found, and the Governor's newsroom for the month.
  • California regulators (Partial): DMHC all-plan letters and rulemaking (browser), CDPH letters and news, HCAI and OHCA, OAL Notice Register, the Standards Board, Medical Board and BRN, CDSS and DTSC were checked. Not done: the index of State Public Health Officer orders was not located; DIR press releases (both addresses return 404); EMSA has no notices list on its new site.
  • CMS newsroom (Reviewed): The dated Newsroom Articles listing covers every article type for the window, and each relevant release was read. The newsroom search page refuses direct requests and was not needed.
  • MLN Connects (Partial): The MLN Connects newsletter index and the November 12 edition, and MLN Matters articles tied to change requests, were checked. Not done: Special Edition articles not tied to a change request have no dated index, so their absence is not proven.
  • CMS transmittals (Reviewed): The 2026 transmittals index was read for the window and each new transmittal opened.
  • Medicare manuals and coverage (Partial): Medicare Coverage Database reports, Cotiviti RAC approved issues (newest July 9, 2026) and Palmetto MolDX news (newest October 9) were checked. Not done: the MCD data ends November 6, so LCDs and articles dated November 7 to 14 are rechecked next run; QPP announcements and listserv messages; the CERT contractor site; the PEPPER portal (sign-in); no dated UPIC listing exists.
  • Medicare Advantage and D-SNP (Reviewed): CMS newsroom dated list and RSS, the D-SNP, rate announcement and bid pages, and the Part C and D enforcement actions table.
  • Medicaid and CHIP (Partial): Medicaid.gov policy guidance and New and Notable, SMD 26-006, the program-integrity page and the DHCS approved SPA list (SPA 26-0020 approved November 5) were read in the browser. Not done: the DHCS pending SPA list prints no dates, and the medicaid.gov California SPA and waiver approval lists were not read.
  • Noridian (Medicare contractor) (Reviewed): Noridian JE Part A and Part B latest updates, articles posted in the window, proposed LCDs, MolDX and Review Choice Demonstration pages; Palmetto MolDX news read in the browser.
  • DHCS (Partial): Read in the browser: managed care APLs, BHINs, news, stakeholder news, CalAIM, the ORP page and deck, SPA lists, Medi-Cal provider news and Medi-Cal Rx bulletins. Not done: HQAF, rates, DSH and directed-payment notices (the HQAF address returns Page not found), provider enrollment and PAVE notices (block page and sign-in), PED pages, and the legacy Medi-Cal newsroom host (unreachable).
  • OIG enforcement (Reviewed): OIG enforcement actions by type and entry page, including the listings OIG's What's New page shows as updated on November 13, 2026, and the CIA browse list with the rolling 90-day view.
  • Justice Department healthcare releases (Reviewed): Every Justice Department and U.S. Attorney press release dated in the window was retrieved through the official press release API and screened. The web listings sit behind a bot check, so the API set could not be cross-checked against them.
  • OCR enforcement (Reviewed): OCR resolution agreements and civil money penalties page and the OCR newsroom read in the browser for the window.
  • FTC health privacy (Reviewed): FTC press releases and the cases and proceedings pages for existing health-privacy matters read in the browser.
  • California enforcement (Partial): DMHC enforcement search with a control search, DMHC press releases, Attorney General releases, the separate Medi-Cal fraud division search and the CDPH enforcement export were checked. Not done: DHCS audit publications; the audits pages render but print no dates for their reports.
  • cms-qso (Reviewed): QSO policy memos for the window, the revised QSO-25-04 transplant memo, and State Operations Manual transmittals.
  • hospital-quality (Reviewed): QualityNet news read in the browser: newest article September 24, 2026, none in the window.
  • cms-price-transparency (Reviewed): The civil money penalty notices list, main page and enforcement activities dataset.
  • prrb-admin (Partial): PRRB decisions 2026-D30 to D34, jurisdictional decisions and alerts were read. Not done: the CMS Administrator decisions listing prints no dates and is not in date order, so decisions issued in the window cannot be identified; the listing is kept for comparison next run.
  • dhcs-eligibility (Reviewed): The 2026 ACWDL and MEDIL lists read in the browser: newest ACWDL 26-22 (October 27); MEDILs I 26-29 to 33 (October 29 to November 4), none from November 8 to 14.
  • oal-actions (Partial): Emergency regulations under review were read. Not done: the Recent Actions table gives no action dates or outcomes, so actions taken in the window (including the two OHCA readopts) are checked against Notice Register 47-Z next run.
  • ca-pharmacy (Reviewed): Pending regulations (no step in the window), alerts, the news archive and the October to December disciplinary list (no facility action; one individual decision in the window) were read.
  • hcai-facilities (Reviewed): HCAI building safety codes and documents modified in the window, and the Hospital Fair Billing Program laws, regulations and policy pages.

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies